Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
September 11 Terrorist Attacks | 8 | 2016 | 21 | 1.660 |
Why?
|
Rescue Work | 9 | 2010 | 15 | 1.350 |
Why?
|
Occupational Diseases | 7 | 2016 | 266 | 1.100 |
Why?
|
Staphylococcal Infections | 2 | 2016 | 115 | 0.810 |
Why?
|
Occupational Exposure | 8 | 2016 | 309 | 0.790 |
Why?
|
Cough | 4 | 2011 | 182 | 0.770 |
Why?
|
Bronchial Hyperreactivity | 5 | 2016 | 29 | 0.690 |
Why?
|
Fires | 6 | 2010 | 12 | 0.690 |
Why?
|
Forced Expiratory Volume | 3 | 2010 | 148 | 0.650 |
Why?
|
Dyspnea | 2 | 2015 | 108 | 0.570 |
Why?
|
Air Pollutants | 4 | 2006 | 84 | 0.550 |
Why?
|
Inhalation Exposure | 4 | 2016 | 57 | 0.550 |
Why?
|
Tricuspid Valve | 1 | 2016 | 19 | 0.510 |
Why?
|
Endocarditis, Bacterial | 1 | 2016 | 30 | 0.510 |
Why?
|
New York City | 13 | 2010 | 75 | 0.500 |
Why?
|
Hypoxia | 1 | 2016 | 108 | 0.490 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 150 | 0.490 |
Why?
|
Substance Abuse, Intravenous | 1 | 2016 | 75 | 0.490 |
Why?
|
Lung | 4 | 2016 | 838 | 0.480 |
Why?
|
Ventricular Function, Right | 1 | 2015 | 27 | 0.480 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 123 | 0.470 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2015 | 47 | 0.470 |
Why?
|
Acute Kidney Injury | 1 | 2016 | 131 | 0.450 |
Why?
|
Ultrasonography | 1 | 2016 | 460 | 0.450 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 171 | 0.440 |
Why?
|
Critical Care | 2 | 2019 | 415 | 0.420 |
Why?
|
Mediastinal Emphysema | 1 | 2011 | 6 | 0.370 |
Why?
|
Rhabdomyolysis | 1 | 2011 | 26 | 0.360 |
Why?
|
Smoke Inhalation Injury | 1 | 2010 | 3 | 0.360 |
Why?
|
Terrorism | 5 | 2004 | 16 | 0.360 |
Why?
|
Renal Insufficiency | 1 | 2011 | 62 | 0.350 |
Why?
|
Radiography, Thoracic | 1 | 2011 | 100 | 0.350 |
Why?
|
Pneumonia, Bacterial | 1 | 2011 | 86 | 0.340 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2010 | 63 | 0.320 |
Why?
|
Budesonide | 1 | 2008 | 10 | 0.300 |
Why?
|
Emergency Medical Services | 2 | 2011 | 251 | 0.300 |
Why?
|
Steroids | 1 | 2008 | 55 | 0.290 |
Why?
|
Spirometry | 5 | 2010 | 94 | 0.290 |
Why?
|
Bronchodilator Agents | 1 | 2008 | 97 | 0.280 |
Why?
|
Lung Diseases | 2 | 2007 | 165 | 0.280 |
Why?
|
Employment | 1 | 2008 | 136 | 0.270 |
Why?
|
Explosions | 2 | 2004 | 6 | 0.270 |
Why?
|
Respiratory Insufficiency | 1 | 2008 | 153 | 0.250 |
Why?
|
Adult | 14 | 2016 | 15887 | 0.250 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 730 | 0.240 |
Why?
|
Environmental Monitoring | 1 | 2005 | 139 | 0.230 |
Why?
|
Depressive Disorder | 1 | 2006 | 293 | 0.220 |
Why?
|
Asthma | 3 | 2007 | 419 | 0.210 |
Why?
|
Dust | 4 | 2007 | 42 | 0.210 |
Why?
|
Echocardiography | 2 | 2016 | 459 | 0.200 |
Why?
|
Follow-Up Studies | 4 | 2015 | 2340 | 0.200 |
Why?
|
Air Pollutants, Occupational | 3 | 2008 | 76 | 0.190 |
Why?
|
Humans | 21 | 2019 | 59849 | 0.180 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 909 | 0.170 |
Why?
|
Intensive Care Units | 2 | 2016 | 452 | 0.170 |
Why?
|
Male | 12 | 2016 | 27790 | 0.160 |
Why?
|
Echocardiography, Transesophageal | 1 | 2019 | 94 | 0.150 |
Why?
|
Gastroesophageal Reflux | 3 | 2005 | 78 | 0.130 |
Why?
|
Prospective Studies | 3 | 2010 | 3110 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2016 | 134 | 0.120 |
Why?
|
Tomography, Spiral Computed | 1 | 2015 | 21 | 0.120 |
Why?
|
Thyroid Crisis | 1 | 2015 | 5 | 0.120 |
Why?
|
Respiratory Function Tests | 3 | 2016 | 165 | 0.120 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 301 | 0.120 |
Why?
|
Polyurethanes | 1 | 2015 | 30 | 0.120 |
Why?
|
Staphylococcus aureus | 1 | 2016 | 159 | 0.120 |
Why?
|
Multiple Organ Failure | 1 | 2015 | 43 | 0.120 |
Why?
|
Female | 9 | 2016 | 31127 | 0.110 |
Why?
|
Bronchial Provocation Tests | 3 | 2016 | 19 | 0.100 |
Why?
|
Heart Arrest | 1 | 2015 | 160 | 0.100 |
Why?
|
Internship and Residency | 1 | 2019 | 736 | 0.090 |
Why?
|
Surveys and Questionnaires | 3 | 2016 | 2601 | 0.090 |
Why?
|
Middle Aged | 8 | 2015 | 16419 | 0.090 |
Why?
|
Community-Acquired Infections | 1 | 2011 | 87 | 0.090 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 65 | 0.090 |
Why?
|
Influenza A virus | 1 | 2011 | 117 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 434 | 0.080 |
Why?
|
Recovery of Function | 1 | 2011 | 264 | 0.080 |
Why?
|
Respiratory Protective Devices | 2 | 2006 | 13 | 0.080 |
Why?
|
Time Factors | 3 | 2006 | 3593 | 0.080 |
Why?
|
Influenza, Human | 1 | 2011 | 193 | 0.080 |
Why?
|
Nebulizers and Vaporizers | 1 | 2008 | 31 | 0.070 |
Why?
|
Ventilators, Mechanical | 2 | 2005 | 31 | 0.070 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2007 | 12 | 0.070 |
Why?
|
Remission, Spontaneous | 1 | 2006 | 13 | 0.070 |
Why?
|
Sick Role | 1 | 2006 | 15 | 0.070 |
Why?
|
Personality Inventory | 1 | 2006 | 50 | 0.070 |
Why?
|
Regression Analysis | 1 | 2008 | 486 | 0.070 |
Why?
|
Bupropion | 1 | 2006 | 8 | 0.070 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2006 | 22 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2006 | 147 | 0.070 |
Why?
|
Disease Progression | 1 | 2010 | 1052 | 0.060 |
Why?
|
Nicotinic Agonists | 1 | 2006 | 39 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 1470 | 0.060 |
Why?
|
Epidemiological Monitoring | 1 | 2005 | 26 | 0.060 |
Why?
|
Electricity | 1 | 2005 | 8 | 0.060 |
Why?
|
Volunteers | 1 | 2005 | 17 | 0.060 |
Why?
|
Nicotine | 1 | 2006 | 111 | 0.060 |
Why?
|
Sputum | 1 | 2004 | 36 | 0.060 |
Why?
|
Disaster Planning | 1 | 2005 | 51 | 0.060 |
Why?
|
Ocular Physiological Phenomena | 1 | 2004 | 2 | 0.060 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2004 | 8 | 0.060 |
Why?
|
Skin Physiological Phenomena | 1 | 2004 | 16 | 0.060 |
Why?
|
Disasters | 1 | 2004 | 28 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2004 | 1059 | 0.050 |
Why?
|
Tobacco Use Disorder | 1 | 2006 | 245 | 0.050 |
Why?
|
Chronic Disease | 1 | 2006 | 741 | 0.050 |
Why?
|
Vital Capacity | 1 | 2003 | 72 | 0.050 |
Why?
|
Comorbidity | 1 | 2005 | 1090 | 0.050 |
Why?
|
Smoking Cessation | 1 | 2006 | 537 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2005 | 424 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 1030 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2006 | 5149 | 0.040 |
Why?
|
Quality of Life | 1 | 2006 | 1129 | 0.040 |
Why?
|
Inflammation | 1 | 2004 | 1106 | 0.040 |
Why?
|
Risk Factors | 1 | 2006 | 5040 | 0.030 |
Why?
|
Methacholine Chloride | 1 | 2016 | 27 | 0.030 |
Why?
|
Computer Simulation | 1 | 2019 | 458 | 0.030 |
Why?
|
Potassium Iodide | 1 | 2015 | 4 | 0.030 |
Why?
|
Methimazole | 1 | 2015 | 8 | 0.030 |
Why?
|
Propranolol | 1 | 2015 | 22 | 0.030 |
Why?
|
Antithyroid Agents | 1 | 2015 | 18 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2015 | 114 | 0.030 |
Why?
|
Resuscitation | 1 | 2015 | 71 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 149 | 0.030 |
Why?
|
Clinical Competence | 1 | 2019 | 685 | 0.030 |
Why?
|
Aged | 2 | 2006 | 13464 | 0.030 |
Why?
|
Prevalence | 1 | 2016 | 1288 | 0.020 |
Why?
|
Mediastinum | 1 | 2007 | 23 | 0.020 |
Why?
|
Directive Counseling | 1 | 2006 | 39 | 0.020 |
Why?
|
Biopsy | 1 | 2007 | 375 | 0.020 |
Why?
|
Aircraft | 1 | 2004 | 17 | 0.010 |
Why?
|
Hospitals, Urban | 1 | 2005 | 44 | 0.010 |
Why?
|
Ambulances | 1 | 2005 | 24 | 0.010 |
Why?
|
Equipment Failure | 1 | 2005 | 65 | 0.010 |
Why?
|
Cell Count | 1 | 2004 | 129 | 0.010 |
Why?
|
Eosinophils | 1 | 2004 | 53 | 0.010 |
Why?
|
Pneumonia | 1 | 2007 | 270 | 0.010 |
Why?
|
Incidence | 1 | 2007 | 1245 | 0.010 |
Why?
|
Particle Size | 1 | 2004 | 402 | 0.010 |
Why?
|
Respiratory Mechanics | 1 | 2002 | 53 | 0.010 |
Why?
|
Neutrophils | 1 | 2004 | 351 | 0.010 |
Why?
|
Infant | 1 | 2005 | 1527 | 0.010 |
Why?
|
Disabled Persons | 1 | 2002 | 205 | 0.010 |
Why?
|
Child, Preschool | 1 | 2005 | 1843 | 0.010 |
Why?
|
Logistic Models | 1 | 2002 | 1252 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 2491 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2005 | 1037 | 0.010 |
Why?
|
Child | 1 | 2005 | 4324 | 0.010 |
Why?
|
Adolescent | 1 | 2005 | 5940 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2005 | 6042 | 0.010 |
Why?
|